Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

558
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
558
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

1.4K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.4K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

1.0K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.0K
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

79
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
79
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

906
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
906
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

294
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
294

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeat CRP measurements and incident myocardial infarction.

American journal of preventive cardiology·2026
Same author

Dialysis Modality, Adequacy and the ESRD Quality Incentive Program Score.

Kidney medicine·2026
Same author

A Prospective, Multicenter, Open-Label Assessment of Efficacy and Safety of the Quanta Dialysis System for Home Hemodialysis.

Kidney medicine·2026
Same author

Core Interventions for the Prevention of Peritoneal Dialysis-Related Infections.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Is Assisted Home Dialysis Feasible in the United States? Addressing Legislative and Regulatory Levers.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Glycemia Assessed by Continuous Glucose Monitoring among People Treated with Maintenance Dialysis.

Journal of the American Society of Nephrology : JASN·2025
Same journal

Variants to Functions to Therapeutic Strategies Toward Genomically Informed Care for Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Personalizing Cardio-Kidney-Metabolic Therapy: Closer But Not There Yet.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Autosomal Dominant Tubulointerstitial Kidney Disease: My Kingdom for a Biomarker.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Beyond the Margin: Improving Noninferiority Trials of Kidney Transplant Immunosuppression.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Parathyroid Hormone Receptor 1 Facilitates Cyst Growth in Genetic Models of Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Alanyl-tRNA Synthetase 1 and Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
06:48

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment

Published on: April 29, 2022

2.8K

The ESRD Quality Incentive Program-Can We Bridge the Chasm?

Daniel Weiner1, Suzanne Watnick2,3

  • 1Department of Medicine, Tufts University, Medford, Massachusetts.

Journal of the American Society of Nephrology : JASN
|March 17, 2017
PubMed
Summary
This summary is machine-generated.

The ESRD Quality Incentive Program (QIP) links dialysis payments to care quality. A patient-centered approach is crucial for improving dialysis care and addressing quality gaps.

Keywords:
Centers for Medicare and Medicaid ServicesQuality incentive programend-stage renal diseaseprospective payment system

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

Related Experiment Videos

Last Updated: Mar 6, 2026

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
06:48

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment

Published on: April 29, 2022

2.8K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

Area of Science:

  • Nephrology
  • Health Policy
  • Quality Improvement

Background:

  • The End-Stage Renal Disease Quality Incentive Program (ESRD QIP) is a mandatory federal pay-for-performance initiative established in 2012.
  • It links 2% of Medicare payments for dialysis facilities to performance on quality of care measures.
  • The program operates within the ESRD prospective payment system, mandated by the Medicare Improvements for Patients and Providers Act of 2008.

Purpose of the Study:

  • To provide an overview of quality assessment and quality measures within the context of the ESRD QIP.
  • To examine the effects of the ESRD QIP on the provision of dialysis care.
  • To discuss potential future directions for quality assessment in ESRD care.

Main Methods:

  • This is a review article, synthesizing information on the ESRD QIP and its implications.
  • It focuses on the evaluation criteria for quality measures, including importance, validity, and performance gap.
  • The review considers the impact of overlapping quality assessment programs and regulatory changes.

Main Results:

  • The ESRD QIP significantly influences care delivery, requiring adaptation from clinicians, patients, and organizations.
  • Frequent regulatory updates and overlapping programs create complexity in quality assessment.
  • The program's structure ties financial incentives directly to measurable quality outcomes in dialysis facilities.

Conclusions:

  • A patient-centered, individualized, and parsimonious approach to quality assessment is essential for the nephrology community.
  • Continued focus on these principles can help bridge the existing quality chasm in dialysis care.
  • The ESRD QIP represents a significant federal effort to enhance the quality of care for patients with end-stage renal disease.